Roth Capital analyst Darren Aftahi lowered the firm’s price target on Core Scientific (CORZ) to $17 from $20 and keeps a Neutral rating on the shares. The company’s deal with CoreWeave (CRWV) will ultimately get done, but at revised economics, the analyst tells investors in a research note. Roth adds that it sees “better risk/reward” elsewhere in its digital infrastructure coverage space.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CORZ:
- Mixed options sentiment in Core Scientific, Inc with shares down 2.95%
- Trump Trade: U.S., EU reach framework agreement on trade
- CoreWeave Insider Sells $147M in Shares as Lock-Up Period Expires
- Waller sees potential for stablecoins to improve retail, cross-border payments
- Moderately bullish activity in Core Scientific, Inc with shares down 3.94%